Ketamine Korner: Edition 13
Ketamine Korner is a bi-weekly newsletter exploring advances in ketamine therapy, originally started by Mind Pain Relief Institute Co-Founder Dr. Rohit Aiyer.
Each edition is republished with permission from Dr. Aiyer.
Latest Research Highlight:
Research Update: One of the defining features of many psychiatric and chronic pain conditions is rigidity—rigid thinking, rigid emotional responses, and repetitive behavioral patterns that can become deeply entrenched over time.
Emerging research suggests ketamine may temporarily enhance cognitive flexibility, or the brain’s ability to shift perspectives, adapt to new information, and move outside repetitive mental loops.
A study published in Translational Psychiatry (Doss et al., 2021) found that ketamine administration was associated with increased psychological flexibility and reductions in maladaptive thinking patterns in patients with depression. Researchers proposed that ketamine’s effects on glutamatergic signaling and neuroplasticity may temporarily alter patterns of neural connectivity associated with rigid thinking and rumination.
Additional neuroimaging work published in Nature and The American Journal of Psychiatry has shown that ketamine may influence communication between large-scale brain networks involved in self-referential thinking, emotional processing, and cognitive control—particularly the default mode network (DMN), which has been implicated in rumination and depressive thinking.
In chronic pain populations, similar mechanisms may be relevant. Persistent pain is often associated with heightened threat prediction, catastrophizing, and learned pain responses. By influencing neuroplasticity and central processing, ketamine may create a temporary therapeutic window in which these patterns become more modifiable.
A Brief History of Cognitive Flexibility in Ketamine Research:
From Symptom Reduction to Network-Level Thinking: Early ketamine research focused primarily on symptom reduction in depression and pain. Over time, researchers became increasingly interested in how ketamine might alter underlying brain function.
The Rise of Neuroplasticity Models: By the 2010s, ketamine’s rapid effects led to theories centered on synaptic plasticity and network reorganization rather than traditional monoamine models alone.
Psychological Flexibility Enters the Conversation: Researchers began observing that many patients described not only mood improvement, but also a greater ability to step outside repetitive thoughts, emotional stuckness, or catastrophic thinking.
Current Perspective: Today, cognitive flexibility is increasingly viewed as a meaningful therapeutic target across multiple conditions—including depression, anxiety, PTSD, and chronic pain syndromes.
Mythbuster:
Myth: Ketamine simply “numbs” emotions or creates temporary dissociation without meaningful psychological change.
Reality:
Research suggests ketamine may temporarily increase cognitive and psychological flexibility, allowing some patients to relate differently to entrenched thoughts and emotional patterns.
These effects are thought to involve changes in neural connectivity and neuroplasticity, not simply sedation or emotional suppression.
The therapeutic value may depend in part on what happens after treatment—including therapy, behavioral change, and integration.
Ketamine is not a substitute for psychological work, but it may help create conditions that potentially support greater engagement with therapeutic interventions in some patients.
Key Takeaway:
Many treatment-resistant conditions involve more than symptoms alone—they involve deeply ingrained patterns of thought, emotion, and nervous system response.
Current research suggests ketamine may help increase flexibility within these systems, potentially allowing some patients to engage more effectively with therapy, rehabilitation, and behavioral change.
As the science evolves, ketamine is increasingly being studied not only as a rapid-acting intervention, but as a tool that may temporarily alter the brain’s capacity for adaptation and change.
As the science evolves, so does our understanding of ketamine’s place in modern psychiatry and pain medicine. Staying informed helps us separate fact from myth and support thoughtful, evidence-based care.
Until next time, stay curious and engaged with the possibilities ahead.